menu ☰
menu ˟

Recombinant growth hormone for idiopathic short stature in children and adolescents

Creator:

Bryant, J., Baxter, L., Cave, C.B. and Milne, R.

Subject Keywords: Pituitary disorder
Topic: Chronic Conditions
Type: Article
Region: International (other)
Description:

Idiopathic short stature (ISS) refers to children who are very short compared with their peers for unknown or hereditary reasons. Recombinant human growth hormone (GH) has been used to increase growth and final height in children with ISS.

The objective of this review is to assess the effects of recombinant human GH on short-term growth and final height in children with ISS.

Date:

21/01/2009

Rights: © The Cochrane Collaboration
Suggested citation:

Bryant, J., Baxter, L., Cave, C.B. and Milne, R.. (2009) Recombinant growth hormone for idiopathic short stature in children and adolescents [Online]. Available from: http://publichealthwell.ie/node/96727 [Accessed: 19th August 2019].

  

View your saved citations and reading lists

Contributor:

Other partner websites
 
Click here to view all the resources gathered from this organisation's website.